Forty-two patients (28 men and 14 women) with acute myocardial infarction (35 Q, seven non-Q wave) were injected with 2.0 mCi indium 111-labeled antimyosin (AM) monoclonal antibody (`111n AM) within 48 hours of the onset of chest pain. Forty-eight hours later (72-96 hours after onset of chest pain), patients were injected with 2.2 mCi thallium 201, and two sets of single-photon emission computed tomography (SPECT) images were obtained simultaneously using dual energy windows set for the 247 keV indium photopeak and the 70 keV thallium peak. Seventeen patients had repeat scans at 4 hours. "'in AM uptake and 201T1 defects were localized to one or more of 24 coronal and sagittal segments. Scans with only 201T1 defects and corresponding "'In AM uptake were classified as matches; scans with unmatched '0TI defects in addition to matching regions corresponding to electrocardiographic infarct location were classified as mismatches; and scans with 20MT1 and`'In AM uptake in the same segments were classified as overlap. Scan patterns were correlated with clinical evidence for residual ischemia occurring within 6 weeks of infarct and including infarct extension, recurrent angina, and positive predischarge low-level or 6-week symptom-limited stress tests and with coronary anatomy. Fourteen patients had only matching patterns (group 1), 23 had mismatches (group 2), and five had 201T1-1'In overlap as the predominant pattern. None of the patients in group 1 had previous myocardial infarction; in each, the matched area corresponded to the Q wave location on electrocardiogram, and none had further in-hospital ischemic events or positive stress tests. In contrast, nine patients in group 2 had previous myocardial infarction, and 16 of the 23 went on to have further evidence of ischemia. There was a significant correlation between further ischemic events and mismatching 201T1-111n AM activity (p<0.01). In conclusion, these results suggest that simultaneous SPECT imaging with 201T1 and`'In AM, performed 72-96 hours postinfarct, might be useful for identifying patients with benign in-hospital courses and those with myocardium at further ischemic risk. (Circulation 1990;81:37-45) E arly hospital discharge for some patients after acute myocardial infarction has been proposed.' It would be useful to identify patients who are likely to have benign postinfarction in-hospital courses early after the acute event. Likewise, identifying patients with further myocardium at ischemic risk early in their hospital course would help direct their physicians toward early catheterization and revascularization by either percutaneous transluminal coronary artery angioplasty (PTCA) or coronary bypass grafting. A decision-making point is at
1 had previous myocardial infarction; in each, the matched area corresponded to the Q wave location on electrocardiogram, and none had further in-hospital ischemic events or positive stress tests. In contrast, nine patients in group 2 had previous myocardial infarction, and 16 of the 23 went on to have further evidence of ischemia. There was a significant correlation between further ischemic events and mismatching 201T1-111n AM activity (p<0.01). In conclusion, these results suggest that simultaneous SPECT imaging with 201T1 and`'In AM, performed 72-96 hours postinfarct, might be useful for identifying patients with benign in-hospital courses and those with myocardium at further ischemic risk. (Circulation 1990 ;81:37-45) E arly hospital discharge for some patients after acute myocardial infarction has been proposed.' It would be useful to identify patients who are likely to have benign postinfarction in-hospital courses early after the acute event. Likewise, identifying patients with further myocardium at ischemic risk early in their hospital course would help direct their physicians toward early catheterization and revascularization by either percutaneous transluminal coronary artery angioplasty (PTCA) or coronary bypass grafting. A decision-making point is at the time of discharge from the coronary care unit, 72-96 hours after the onset of chest pain.
Antimyosin is a Fab fragment of a monoclonal antibody that binds with human myosin exposed in myocytes irreversibly damaged by an ischemic event. [2] [3] [4] Tagged with indium 111, the antibody is taken up into acutely necrotic tissue and can be imaged by planar or single-photon emission computed tomography (SPECT) techniques. Two multicenter clinical trials have demonstrated a high degree of sensitivity for detecting infarction and specificity for excluding a recent ischemic event in patients admitted with chest pain syndrome.5-8 Reduced uptake of thallium 201 immediately after injection reflects reduced regional myocardial blood flow but not necessarily nonviability. Identifying reduced flow in myocardial regions outside of the area of actual necrosis from simultaneous dual isotope 'llIn-_20T1 SPECT scans could potentially be useful for identifying patients at further ischemic risk.
The purpose of this study was to test the hypothesis that myocardium not in the vascular distribution of previous Q wave infarct, taking up neither thallium nor indium antimyosin on simultaneous dual isotope SPECT acquisition, is potentially viable, thereby placing the patient at increased risk. 
Methods

Imaging
At about 48 hours after antibody administration, patients were brought to the nuclear cardiology laboratory and 2.0-2.2 mCi 20`T1 was injected intravenously. After a 5-10-minute equilibration time, SPECT acquisition was performed using simultaneous dual isotope acquisition with the two energy windows set for the 70 keV photopeak of 201T1 and the high (247 keV) photopeak of "'In.
Imaging on the first 10 patients studied was performed with a rotating dual-head digital gamma camera (Picker International, Northford, Connecticut) equipped with medium-energy parallel-hole collimators. Data were acquired by each head from 30 equally spaced 60-second stops over a 1800 elliptical arc yielding 3600 acquisition with 60 total projection images. A total of approximately 1.5 million counts were obtained. Digital tomographic data were acquired in a 64x64 word matrix using commercial software (MIPS, Ann Arbor, Michigan). Imaging on the last 32 patients studied was performed with a rotating single-head digital gamma camera (Picker SX 300, Picker International), equipped with a medium energy parallel-hole collimator. Data were acquired from 32 equal 60-second stops over a 1800 elliptical orbit starting at the left posterior oblique projection. These studies contained approximately 650,000 counts. Digital data were in a 64x64 word matrix using a different commercial software package (Picker).
The last 17 patients enrolled were maintained in the fasting state and returned to the laboratory 4 hours later, and a repeat dual isotope scan was acquired using the same acquisition parameters. Coronary Angiography Twenty-six of 42 patients underwent catheterization either during the admission for the acute infarction or within 6 weeks of the event. Early catheterization (within 48 hours of antimyosin injection) was performed in 11, five of whom were involved in a thrombolytic protocol, the other six for recurrent angina, infarct extension, or both. The remaining 15 patients were studied for other clinical indications that included postinfarction recurrent symptoms of ischemia in 12, first infarct at a young age in two, or postinfarction failure in one. The time between antimyosin injection and angiography in these 15 averaged 11.3±10.5 days with a range of 3-41 days. Data Analysis Projection images acquired on both systems from the indium and thallium scans were reconstructed into 2-pixel-thick oblique coronal and sagittal slices by filtered back projection using a 0.15 Butterworth filter for the dual head data and a Metz prefilter plus ramp filter for the single-head data.
Coronal slices from base to apex for the simultaneously acquired thallium and indium SPECT studies were displayed together on a color video display. Likewise, the simultaneously acquired sagittal slices from septum to lateral wall were displayed. The images were read by consensus of three observers blinded to patients' identities (L.L.J., D.W.S., R.M.W.). Both antimyosin uptake and thallium defects were localized to one or more of 24 segments from coronal and sagittal slices. Thallium defects with indium antimyosin uptake corresponding in size and location were classified as matches; thallium defects without corresponding antimyosin uptake were classified as mismatches; and regions of uptake of both thallium and antimyosin in the same location were classified as overlap. In addition to localization, the intensity of antimyosin activity uptake was graded as intense (.hepatic uptake), moderate (<hepatic but clearly >back-ground), and faint (just slightly >background). Heart to background count ratios for each study were calculated from the reconstructed slice having the highest counts in the heart. Range of ratios was 2.2-38.7. All studies read qualitatively to have faint antimyosin uptake had heart to background ratios below 3.30. Because of difficulty determining the borders of faint uptake, scans showing faint antimyosin uptake in regions corresponding to 2`1T1 defects were read as mismatches.
Scan patterns were correlated with subsequent ischemic events defined as either infarct extension, recurrent in-hospital angina, positive predischarge exercise stress test, or positive exercise thallium stress test at 6 weeks. Statistics Correlation between presence or absence of unmatched thallium perfusion defects and ischemic events was assessed using Fisher's exact test. Group comparisons were made using Student's t test.
Results
Scan Results
In 14 patients, there was correspondence between thallium defects and antimyosin uptake (group 1) (Figures 1 and 2 ). Twenty-three had mismatching 201T1-`11In antimyosin activity in addition to matching regions corresponding to electrocardiographic infaret location (group 2) (Figures 3 and 4) . Five scans showed 201T1-`In overlap (group 3). Because the overlap group was small, only groups 1 and 2 were compared statistically. There was no difference in the number of successfully reperfused patients between group 1 (two of 14) and group 2 (four of 23). The mean peak creatine kinase (CK) -MB value was higher in group 1 (142+131 IU) than group 2 (68+74 IU) but the difference was not statistically significant (p=0.1).
Matching Thallium Defect-Indium AM Uptake
None of the 14 patients in group 1 had a history of previous infaretion. By ECGG the acute infaret was anterior in six and inferoposterior in eight patients. In all 14, the electrocardiographic infarct location, thallium defect location, and antimyosin uptake location agreed (Table 1) . In one patient, the thallium SPECT showed no defect. The indium antimyosin SPECT showed tracer uptake in the region of right ventricle (RV). The gated blood pool scan before discharge showed normal left ventricular ejection fraction and wall motion and a RV infarct. Six of the 14 had coronary angiography because of first infarct at a young age, and four had single-vessel disease; one had normal coronaries in the clinical setting of cocaine-induced infarction and thrombolytic therapy; and one had multivessel disease (Table 1) . Mismatching Thallium Defect-Indium AM Uptake Of the 23 patients with mismatches (thallium defect greater than antimyosin uptake), nine had a history of previous infarct (see Table 1 ). The Recurrent chest pain occurred in 10, with evidence for infarct extension by CK-MB bump in three of 10. The postinfaret chest pain occurred 2-7 days after scanning in seven of 10 and within 24 hours of scanning in three of 10. Positive stress tests with evidence for residual ischemia occurred in six; four were routine predischarge low level, one predischarge gated blood pool scan, and one 6-week stress thallium. One patient (32) had no evidence for ischemia on predischarge stress test and a 38% predischarge ejection fraction. Four weeks after discharge, she was admitted to another hospital with ischemic pulmonary edema.
Of the 16 group 2 patients with events, the unmatched thallium defect was in the same vascular distribution as the acute infaretion in six, and in a different vascular distribution in 10 10 had previous non-Q wave infarcts. Five of seven group 2 patients without events had previous Q wave infarctions, and the unmatched thallium defect was in the vascular distribution of the previous infarcts. One patient had a large left anterior descending coronary artery (LAD) infarct with more extensive thallium defect than antimyosin uptake. One patient had an acute inferior infarction with an inferior thallium defect and no discernible antimyosin uptake (false-negative scan).
Thallium Redistribution
Six of the 17 patients with 4-hour redistribution thallium scans were in group 1, 10 were in group 2, and one in group 3 ( Table 2) . Five of six with matched antimyosin uptake-thallium defect showed no thallium redistribution over 4 hours. One patient with a large LAD infarct showed some redistribution within the infarct territory. Of the 11 group 2 and group 3 patients with 4-hour thallium scans, four showed redistribution. The locations of the unmatched thallium defects on the dual isotope scans corresponded to the locations of thallium redistribution in all four (Table 2 and Figure 6 ).
Discussion
In this group of patients with acute myocardial infarction, all 14 patients with matched thallium defects and antimyosin uptake had benign in-hospital courses and subsequent negative exercise stress tests. In these patients, all segments of myocardium took up either thallium (viable and not ischemic at rest) or took up antimyosin (acutely infarcted). In contrast to the benign courses of the patients with matched scans, 16 of 23 patients with mismatched patterns went on to have further ischemic events. Myocardium taking up neither thallium (on immediate imaging) nor antimyosin represents either old scar, viable myocardium with reduced blood flow due to decreased supply (ischemia), or slowly recovering or "stunned" myocardium.9 The high incidence of further ischemic events indicates that many patients in this group had viable myocardium at further risk. Only five patients had predominantly overlapping thallium and antimyosin uptake in the same myocardial segments. Three had non-Q wave infarcts. Overlapping of thallium and antimyosin can represent either nontransmural necrosis occurring in the distribution of the infarct vessel or more extensive nontransmural necrosis occurring beyond the limits of a Q wave infarct. Although the numbers are small, a high percentage of this small group had further events.
To plan invasive studies, it is important clinically to identify, early in their hospital courses, patients who still have myocardium at further ischemic risk. The data from this study suggest that patients with mismatches, especially in the absence of previous infarction, are candidates for early coronary angiography preliminary to revascularization if anatomically feasible. The anatomical correlates in this group with mismatches are either successful reperfusion with tight residual stenosis in the infarct vessel, stenoses in the distribution of other (noninfarct-related) vessels, or both.
It is equally important to identify, early, patients who will have stable in-hospital postinfarction courses. These patients can be candidates for early hospital discharge. A time of decision is frequently around 72 hours postinfarction or time of coronary care unit discharge. Topol et all0 performed stress thallium studies 72 hours after infarction in 53 patients who had undergone reperfusion. Thirty-six patients showed fixed perfusion defects without redistribution and none of these patients had further in-hospital cardiac events. Such a protocol is not applicable to all postinfarction patients. Many patients are not stable enough for stress testing at 72 hours.
Thallium redistribution has been shown in experimental animals and in humans to be a marker of myocardial viability."11,2 Although only 17 of 42 patients in this present study had 4-hour thallium scans, redistribution in the territory corresponding to the unmatched thallium defect on the dual isotope scan was seen in four, confirming viability in these segments. Defects at rest on thallium scans that redistribute over 2-4 hours have been demonstrated in patients with stable severe coronary disease and presumably represent reduced resting blood flow in the distribution of severely stenotic coronary arteries. '3 Thallium defects at rest that redistribute have been shown to be sensitive but not specific for predicting future ischemic events in patients admitted to the hospital with unstable angina.14 In experimental acute infarct studies and in humans, decrease in size of thallium perfusion defects (by either redistribution or second injection) has been demonstrated when the initial injection and scans are obtained early (less than 24 hours) after the onset of chest pain or mismatches with reduced thallium uptake but absent antimyosin uptake (excluding previous infarctions).
The major advantage of this dual isotope protocol is that it involves only a single-imaging procedure at rest, which is particularly important for patients in the immediate postinfarction period. "1'In and 2`1T1 are well suited for simultaneous dual isotope imaging because the high photopeak of`11In is widely separated from the 70 keV photopeak of 20`T1. Using this same protocol in animals, we have previously shown that the average percentage of total counts over the left ventricular region of interest on the thallium scans that represented downscatter from the indium activity into the thallium window equaled 12%.2o The relatively slow blood clearance of antimyosin is not a limitation to this protocol. When injected within 48 hours of the onset of chest pain, optimal imaging time corresponds to coronary care discharge.
Because only 17 of the 42 patients had redistribution thallium SPECT imaging, the relative usefulness of dual isotope SPECT imaging, compared with rest and redistribution thallium SPECT imaging alone, in this population of patients 48-96 hours postinfarction cannot be addressed. There are, however, several potential advantages to simultaneous dual isotope imaging, compared with thallium rest and redistribution imaging, for identifying myocardium at further ischemic risk. One advantage is detection of overlapping activity from 201T1 and`I11n antimyosin in the same myocardial regions, possibly representing nontransmural necrosis. The other is detection of an unmatched thallium defect, on dual isotope imaging, which shows very slow or absent thallium redistribution despite viability. Delayed (24-hour) redistribution images can enhance viability detection. If a single set of dual isotope images can give the same or possibly more information than two or three sets of thallium images, however, then the dual isotope method is both time and cost efficient.
The variability in the intensity of antimyosin uptake is a potential drawback to the correct classification of the dual thallium antimyosin scans. All factors determining the intensity of`1In antimyosin uptake into infarets in humans have not been fully determined. In a small series of patients with early catheterization and mostly nonreperfused Q wave infarcts, we have previously shown that faint antimyosin uptake in Q wave infarcts correlates with inferoposterior location and infarct vessel occlusion in the absence of good collaterals.5 Other studies have reported that intensity of tracer uptake in humans, however, is not related to infarct location, patency of infarct vessel, or Q waves on ECG.7,8 If antimyosin uptake was too faint to allow definition of the extent, even if uptake was in the same vascular distribution as the infarct by ECG and thallium defect, the scan was classified as a mismatch. Twelve of 23 patients in group 2 had faint or absent antimyosin uptake; nine of 12 had inferoposterior infarets. Unmatched inferoposterior thallium defects can represent either necrosis with poor antimyosin uptake or viability with reduced flow. 
